Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage

Tong Ling; Wei Xian-jiang

Your Location：

Home >

Browse articles >

Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage

中国医学科学杂志（英文版） 2016年31卷第4期页码：239-246

Orginal Article | Updated：2024-04-10

- Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage
- Affiliations：
  
  1. Department of Gynaecology and Obstetrics, XiXi Hospital of Hangzhou, Hangzhou, 310023, China
  2. Department of Gynaecology and Obstetrics, Hangzhou Red Cross Hospital, Hangzhou 310000, China
- Author bio：
  
  *Corresponding author Tel: 86-0517-86481556, xxyylingtong@aliyun.com
- Funds：
- DOI：
  中图分类号：
- 网络出版日期：2016-08-20，
  
  纸质出版日期：2016-08
- Accepted：
Scan QR Code
Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage[J]. 中国医学科学杂志（英文版）, 2016,31(4):239-246.

Tong Ling, Wei Xian-jiang. Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage[J]. Chinese medical sciences journal, 2016, 31(4): 239-246.
Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage[J]. 中国医学科学杂志（英文版）, 2016,31(4):239-246. DOI：

Tong Ling, Wei Xian-jiang. Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage[J]. Chinese medical sciences journal, 2016, 31(4): 239-246. DOI：

摘要

Abstract

Objective

This study was designed to evaluate the efficacy and safety of aspirin-heparin treatment for un-explained recurrent spontaneous abortion (URSA).

Methods

Literatures reporting the studies on the aspirin-heparin treatment of un-explained recurrent miscarriage with randomized controlled trials (RCTs) were collected from the major publication databases. The live birth rate was used as primary indicator

preterm delivery

preeclampsia

intrauterine growth restriction

and adverse reactions (thrombocytopenia ) were used as the secondary indicators. The quality of the included studies was evaluated using RCT bias risk assessment tool in the Cochrane Handbook (v5.1.0). Meta-analysis was conducted using RevMan (v5.3) software. Subgroup analyses were conducted with an appropriately combined model according to the type of the treatments if heterogeneity among the selected studies was detected.

Results

Six publications of RCTs were included in this study. There were a total of 907 pregnant women with diagnosis of URSA

367 of them were pooled in the study group with aspirin-heparin therapy and 540 women in the control group with placebo

aspirin or progesterone therapy. Meta-analysis showed that the live birth rate in the study group was significantly different from that in the control group [

= 1.18

95%

(1.00-1.39)

=0.04]. Considering the clinical heterogeneity among the six studies

subgroup analysis were performed. Live birth rates in the aspirin-heparin treated groups and placebo groups were compared and no significant difference was found. There were no significant differences found between the two groups in the incidence of preterm delivery [

=1.22

95%

(0.54-2.76)

=0.64]

preeclampsia [

=0.52

95%

(0.25-1.07)

=0.08]

intrauterine growth restriction [

=1.19

95%

(0.56-2.52)

=0.45] and thrombocytopenia [

=1.17

95%

(0.09-14.42)

=0.90].

Conclusion

This meta-analysis did not provide evidence that aspirin-heparin therapy had beneficial effect on un-explained recurrent miscarriage in terms of live birth rate

but it was relatively safe for it did not increase incidence of adverse pregnancy and adverse events. More well-designed and stratified double-blind RCT

individual-based meta-analysis regarding aspirin-heparin therapy are needed in future.

关键词

Keywords

references

Kuon RJ , Wallwiener LM , Germeyer A , et al. Establishment of a standardized immunological diagnostic procedure in RM patients. J Reprod Immunol 2012 ; 94 : 55 .

Xiao SJ , Zhao AM. The etiology of recurrent spontaneous abortion research. Chin J Gynecol Obstet 2014 ; 30 : 41 - 5 .

Cohen M , Bischof P. Factors regulating trophoblast invasion. Gynecol Obstet Invest 2007 ; 64 : 126 - 30 .

Christiansen OB , Nybo Andersen AM , Bosch E , et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005 ; 83 : 821 - 39 .

Luo QY , Chen BJ , Wu DJ , et al. Comparative analysis of the efficacy of five methods in treating the un-explained recurrent spontaneous abortion. China Prac Med 2009 ; 4 : 16 - 7 .

Wang ZH , Zhang JP. Prothrombotic state with recurrent miscarriage and anticoagulant therapy. Chin J Gynecol Obstet 2013 ; 29 : 102 - 6 .

Rai R , Backos M , Baxter N , et al. Recurrent miscarriage- an aspirin a day? Hum Reprod 2000 ; 15 : 2220 - 3 .

Brenner B , Hoffman R , Blumenfeld Z , et al. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000 ; 83 : 693 - 7 .

Clark,P , Walker ID , Langhorne P , et al . SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010 ; 115 : 4162 - 7 .

Kaandorp,SP. Goddijn M , van der Post JA , et al . Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010 ; 362 : 1586 - 96 .

Visser J , Ulander VM , Helmerhorst FM , et al. Thrombo- prophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost 2011 ; 105 : 295 - 301 .

Elmahashi , MO Elbareg AM , Essadi FM , et al . Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. BMC Res Notes 2014 ; 7 : 23 .

Wang HJ. Li ZY. Efficacy of heparin and aspirin in treating the un-explained recurrent spontaneous abortion. J Int Obstet & Gynecol 2014 ; 41 : 207 - 8 .

Wang L. Efficacy of the heparin and aspirin therapy for un-explained recurrent miscarriage. J Chin Prescription Drug 2014 ; 12 : 50 .

de Jong PG , Kaandorp S , Di Nisio M. et al. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev 2014 ;7: CD004734.

Allison JL , Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes 2009 ; 16 : 446 - 450 .

Qiu GX , Dai KR , Yang QM , et al. Expert advice on the prevention of deep venous thrombosis after major ortho- pedic surgery-abstract of the seminar about prevention of deep venous thrombosis. Chin J Orthop 2005 ; 10 : 636 - 40 .

Dong XM , Du XZ , Zhao CS , et al. Research progress in thrombophilia and recurrent spontaneous abortion. Lab Med Clin 2013 ; 10 : 197 - 200 .

Yang QL , Mi JF. Application and development of aspirin in the treatment of recurrent miscarriage. Guide China Med 2011 ; 9 : 41 - 2 .

浏览量

1754

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

Transarterial Embolization versus Translumber Embolization for Type Ⅱ Endoleak after Endovascular Abdominal Aortic Aneurysm Repair: A Meta-Analysis

Effects of Exercise on Cancer-related Fatigue and Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Meta-analysis of Randomized Clinical Trials

Efficacy of Short-term Dual Antiplatelet Therapy after Implantation of Second-generation Drug-eluting Stents: A Meta-analysis and Systematic Review

Efficacy of Topical Tacrolimus for Erosive Oral Lichen Planus: A Meta-analysis

Association between Two Polymorphisms of Follicle Stimulating Hormone Receptor Gene and Susceptibility to Polycystic Ovary Syndrome: a Meta-analysis